Director Juan R. Luciano filed a Form 4 with the SEC on November 17, 2026, disclosing two acquisitions of Eli Lilly & Co common stock on November 16, 2026, at a price of $1,431.67 per share.
Key Highlights
- Reporting person: Juan R. Luciano, identified as a Director of Eli Lilly & Co (NYSE:LLY).
- First acquisition: 11.1176 shares acquired on November 16, 2026, at $1,431.67 per share, bringing beneficial ownership to 16,980.7639 shares.
- Second acquisition: 167.6364 shares acquired on November 16, 2026, at $1,431.67 per share, bringing beneficial ownership to 17,148.4003 shares directly held.
- Deferred compensation: The 11.1176 shares in the first transaction were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan, to be settled in common stock following separation from service.
- Transaction code: Both transactions are coded "A" (acquisition), with direct ownership form for each.
- Filing signed: Jonathan Groff, acting for Juan R. Luciano pursuant to authorization on file, signed the filing on November 17, 2026.
Juan R. Luciano's November 2026 Share Acquisitions at Eli Lilly
According to the Form 4 filing, Director Juan R. Luciano reported two separate acquisitions of Eli Lilly & Co common stock, both occurring on November 16, 2026, and both priced at $1,431.67 per share. The first transaction involved 11.1176 shares. The filing states that these shares "have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service," reflecting an election made by Luciano.
The second transaction recorded 167.6364 shares acquired directly. Following this transaction, Luciano's total direct beneficial ownership of Eli Lilly common stock stood at 17,148.4003 shares, according to the filing. Both acquisitions are listed under Table I as non-derivative securities and carry direct ownership designation. No derivative securities were reported in Table II.
The filing was submitted on November 17, 2026, and was signed by Jonathan Groff on behalf of Juan R. Luciano pursuant to an authorization on file. Luciano's address is listed as Lilly Corporate Center, Indianapolis, Indiana 46285.
What Was Disclosed
Director Juan R. Luciano disclosed two acquisitions of Eli Lilly & Co common stock on November 16, 2026, totaling approximately 178.7540 shares at $1,431.67 each. The first acquisition was deferred under the Lilly Directors' Deferral Plan; the second was a direct holding.




Please wait processing your request...